All Posts | Links Medicus - Free Medical News & Perspective

New from @ErasmusMC: endoscopists performing colonoscopy in FIT-based screening programs should aim for higher ADRs compared w/ programs that use colonoscopy as primary screening intervention: https://t.co/Fob1gxXF1i pic.twitter.com/y6qoAkOrT9

— Annals of Int Med (@AnnalsofIM) September 30, 2022

M-A | Beta-blocker treatment in the critically ill.

4 Oct, 2022 | 14:30h | UTC

Beta-blocker treatment in the critically ill: a systematic review and meta-analysis – Annals of Medicine

RCT | Prucalopride did not improve time to gut function recovery following elective colorectal surgery.

4 Oct, 2022 | 14:29h | UTC

Effect of prucalopride to improve time to gut function recovery following elective colorectal surgery: randomized clinical trial – British Journal of Surgery

Commentary on Twitter

https://twitter.com/BJSAcademy/status/1574687035805339649

Systematic Review | Compression following treatment of superficial venous incompetence.

4 Oct, 2022 | 14:28h | UTC

Compression following treatment of superficial venous incompetence: systematic review – British Journal of Surgery (link to abstract – $ for full-text)

Review | Poor physical recovery after critical illness.

4 Oct, 2022 | 14:27h | UTC

Poor physical recovery after critical illness: incidence, features, risk factors, pathophysiology, and evidence-based therapies – Current Opinion in Critical Care

AAP Clinical Report | Controlling and treating head lice in children and adolescents.

3 Oct, 2022 | 14:04h | UTC

Head Lice – Pediatrics

News Release: American Academy of Pediatrics Updates Report on Controlling and Treating Head Lice in Children, Adolescents – American Academy of Pediatrics

AAP Recommendations | Prevention of pediatric all-terrain vehicles related deaths and injuries.

3 Oct, 2022 | 14:05h | UTC

American Academy of Pediatrics Recommendations for the Prevention of Pediatric ATV-Related Deaths and Injuries – Pediatrics

Technical Report: A Comprehensive Report on All-Terrain Vehicles and Youth: Continuing Challenges for Injury Prevention – Pediatrics

Commentaries:

ATVs Are Not Safe for Children: AAP Policy Explained – Health Children

AAP Calls for Prevention of Pediatric ATV-Linked Deaths, Injuries – HealthDay

AAP Clinical Report | Evaluation for bleeding disorders in suspected child abuse.

3 Oct, 2022 | 14:03h | UTC

Evaluation for Bleeding Disorders in Suspected Child Abuse – Pediatrics’

Technical Report: Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding – American Academy of Pediatrics

Commentary: AAP guidance helps distinguish bleeding disorders from abuse – MDedge

Consensus Recommendations | Priority activities to address acute kidney injury in children.

3 Oct, 2022 | 14:01h | UTC

Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children: A Modified Delphi Consensus Statement – JAMA Network Open

Invited Commentary: Highlights of Consensus-Based Recommendations for Acute Kidney Injury in Children – JAMA Network Open

Commentary on Twitter

https://twitter.com/JAMANetworkOpen/status/1575893237201600517

Cohort Study | Diabetes diagnosed at younger ages is associated with increased morbidity compared to diagnosis in older adults.

3 Oct, 2022 | 14:02h | UTC

Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults – JAMA Network Open

M-A of randomized trials | Colchicine and coronary heart disease risks.

3 Oct, 2022 | 14:00h | UTC

Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials – Frontiers in Cardiovascular Medicine

M-A: Colchicine after percutaneous coronary intervention significantly reduces the risk of major adverse cardiovascular events in patients with symptomatic coronary artery disease.

Expert Analysis | Colchicine in acute coronary syndrome: when to commence?

M-A: Colchicine in patients with coronary artery disease – “colchicine reduces the risk of myocardial infarction and stroke, but has a higher rate of gastrointestinal upset with no influence on all‐cause mortality”.

Review: Colchicine and the heart.

M-A: Colchicine administration for percutaneous coronary intervention

M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease

Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease

#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome

#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

#AHA19 – [Abstract Only] Practice Changing? – Randomized Trial: Low-Dose Colchicine Improves Outcomes after Myocardial Infarction

Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

Guideline | Operative management of acute abdomen after bariatric surgery in the emergency setting.

3 Oct, 2022 | 13:59h | UTC

Operative management of acute abdomen after bariatric surgery in the emergency setting: the OBA guidelines – World Journal of Emergency Surgery

Brief review | Optimal sedation strategy for critically ill patients.

3 Oct, 2022 | 13:56h | UTC

Seeking the Light in Intensive Care Unit Sedation: The Optimal Sedation Strategy for Critically Ill Patients – Frontiers in Medicine

Long-term follow-up of a RCT | P2Y12 inhibitor monotherapy vs. DAPT after percutaneous coronary intervention.

3 Oct, 2022 | 13:58h | UTC

Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)

Original Study: Randomized Trials: Shorter Duration of Dual Antiplatelet Therapy May be an Option for Patients Undergoing Percutaneous Coronary Intervention

Commentary on Twitter

In #RCT follow-up, P2Y12 inhibitor monotherapy after 3 months of DAPT found to be comparable with prolonged DAPT for preventing ischemic events. P2Y12 inhibitor monotherapy resulted in significantly lower rate of major bleeding for up to 3 yrs. https://t.co/pBv9X87lEg #Research pic.twitter.com/42Y28hPPT2

— JAMA Cardiology (@JAMACardio) September 30, 2022

RCT | A behavioral intervention delivered by text messages did not reduce sexually transmitted reinfections in young people.

3 Oct, 2022 | 13:57h | UTC

Effectiveness of a behavioural intervention delivered by text messages (safetxt) on sexually transmitted reinfections in people aged 16-24 years: randomised controlled trial – The BMJ

News Release: Texting young people about safe sex does not reduce STI reinfection – BMJ Newsroom

Commentary on Twitter

New research: Sending regular texts to young people who have recently had a sexually transmitted infection (#STI) to encourage #safesex does not reduce rates of chlamydia and gonorrhoea reinfection, finds a trial published by @bmj_latest today.https://t.co/OgQqPAsbS7 pic.twitter.com/0QTLqPuzDX

— BMJ Group (@bmj_company) September 29, 2022

Review | Acute kidney injury in patients with liver disease.

3 Oct, 2022 | 13:56h | UTC

Acute Kidney Injury in Patients with Liver Disease – Clinical Journal of the American Society of Nephrology

Commentary on Twitter

AKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcomes. This article discusses tailoring management of AKI in patients with liver disease to the specific underlying etiology https://t.co/UVEeYBL8ff @VelezNephHepato pic.twitter.com/V5J8hBQyuw

— CJASN (@CJASN) September 27, 2022